-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Eton Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q1 2024.
- Eton Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $821K, a 5.85% decline year-over-year.
- Eton Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $3.09M, a 23% decline year-over-year.
- Eton Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.14M, a 25.6% decline from 2022.
- Eton Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.22M, a 24.8% increase from 2021.
- Eton Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.38M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)